Aimei Health Technology Co., Ltd. (AFJK) Financial Statements
Industry: Blank Checks
In fiscal 2025, Aimei Health Technology reported revenue of $0. Net income was $1.1M, or $0.17 per diluted share. Operating activities generated -$565,100 of cash. At fiscal year end, Aimei Health Technology held $12.1M in total assets against $4.1M in total liabilities.
Open the full interactive Aimei Health Technology financials → Quarterly statements, key ratios, valuation history and price charts.
Aimei Health Technology Key Stats
| Share Price | $12.50 |
|---|---|
| Market Cap | $26.6M |
| P/E Ratio | 73.5 |
| 52-Week Range | $8.00 – $88.50 |
| Shares Outstanding | 2.1 million (basic, 2026 Q2) |
Aimei Health Technology Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Goods Sold | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$1.1M | -$835,759 |
| Pre-Tax Income | $2.6M | $1.1M |
| Income Tax | $0 | $0 |
| Net Income | $2.6M | $1.1M |
| Diluted EPS | $0.28 | $0.17 |
Aimei Health Technology Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | $352,019 | $98,117 | $45,440 | -$83,144 |
| Diluted EPS | $0.06 | $0.02 | $0.01 | -$0.03 |
Aimei Health Technology Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Current Assets | $30,384 | $2,929 |
| Total Assets | $73.8M | $12.1M |
| Current Liabilities | $816,994 | $3.4M |
| Total Liabilities | $1.5M | $4.1M |
| Shareholders' Equity | -$1.5M | -$4.1M |
Aimei Health Technology Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$672,289 | -$565,100 |
| Cash From Investing | -$277,700 | $63.6M |
| Cash From Financing | $397,480 | -$63.0M |
Figures from Aimei Health Technology's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Aimei Health Technology financials page for every line item.
Aimei Health Technology Company Profile
| Ticker | AFJK |
|---|---|
| Exchange | Nasdaq |
| Industry | Blank Checks |
| Headquarters | New York, New York |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001979005 |
Frequently Asked Questions
What was Aimei Health Technology's revenue in fiscal 2025?
Aimei Health Technology (AFJK) reported revenue of $0 for fiscal 2025.
What was Aimei Health Technology's net income in fiscal 2025?
Aimei Health Technology reported net income of $1.1M for fiscal 2025.
What was Aimei Health Technology's earnings per share (EPS) in fiscal 2025?
Aimei Health Technology's diluted EPS was $0.17 for fiscal 2025 (adjusted for any later stock splits).
What was Aimei Health Technology's revenue last quarter?
In its most recent reported quarter (2026 Q2), Aimei Health Technology reported revenue of $0.
How many shares of Aimei Health Technology are outstanding?
Aimei Health Technology reported a weighted average of 2.1 million basic shares outstanding in 2026 Q2.
What is Aimei Health Technology's market cap?
Based on its latest closing price, Aimei Health Technology (AFJK) has a market capitalization of about $26.6M.
When does Aimei Health Technology's fiscal year end?
Aimei Health Technology's fiscal year end, as registered with the SEC, is December 31.
Where is Aimei Health Technology headquartered?
Aimei Health Technology lists its business address in New York, New York in its SEC filings.